Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
25(OH)D3
15%
25-hydroxyvitamin D3
17%
Atopic Dermatitis
31%
Complete Remission
16%
Complete Response
28%
COVID-19
17%
Cutaneous Leishmaniasis
58%
Cutaneous Melanoma
18%
Hypertrophic Lichen Planus
17%
Israel
73%
Jews
26%
Lamb
30%
Leishmania Braziliensis
17%
Leishmania Major
20%
Leishmania Tropica
26%
Malignant Melanoma
26%
Medical Center
17%
Melanocytic Nevus
17%
Melanoma
34%
Melanoma Patients
16%
Melanoma Risk
21%
Mycosis Fungoides
65%
Narrowband Ultraviolet B Phototherapy
19%
Narrowband UVB
50%
Neural Systems
17%
Nevus
17%
Odds Ratio
19%
Outdoor Workers
22%
Pediatric Psoriasis
17%
Pemphigus Vulgaris
22%
Phototherapy
62%
Psoralen
21%
Psoriasis
78%
Psoriasis Disease
25%
Psoriasis Treatment
17%
Psoriatic Arthritis
35%
Remission
20%
Retrospective Cohort Study
31%
Risk Factors
21%
Rituximab
24%
Rituximab Therapy
17%
Serum Levels
17%
Sodium Stibogluconate
31%
Sun Exposure
18%
Sun Protection
17%
Systemic Treatment
18%
Travellers
18%
Treatment Response
22%
Tumor
28%
Ultraviolet-B (UV-B)
100%
Medicine and Dentistry
Adolescence
11%
Atopic Dermatitis
28%
Biological Product
16%
Calcifediol
17%
Clinical Trial
10%
Cohort Analysis
22%
Cutaneous Leishmaniasis
21%
Cutaneous T Cell Lymphoma
9%
Diseases
42%
Electronic Patient Record
8%
Infection
10%
Leishmania Major
9%
Lentigo
13%
Lichen Planus
26%
Lymphocyte
11%
Medical Record
11%
Melanocytic Nevus
18%
Melanoma
57%
Methotrexate
10%
Mycosis fungoides
70%
Nevus
20%
Occupational Exposure
11%
Odds Ratio
23%
Oral
13%
Pediatrics
10%
Pemphigus vulgaris
20%
Photochemotherapy
17%
Phototherapy
65%
Prevalence
10%
Prognostic Factor
11%
Psoralen
29%
Psoriasis
77%
Psoriatic Arthritis
8%
PUVA
17%
Quality of Life
10%
Retrospective Cohort Study
22%
Retrospective Study
21%
Rituximab
26%
Side Effect
10%
Skin Cancer
19%
Skin Type
9%
Sodium Stibogluconate
8%
Sun Exposure
24%
Sun Protection
17%
Sunscreen
13%
Systemic Therapy
11%
Treatment Modality
9%
Treatment Response
19%
Tumor
20%
Vitiligo
23%